Research ArticleClinical Studies
Skin Reaction to Cetuximab as a Criterion for Treatment Selection in Head and Neck Cancer
PRIMOŽ STROJAN, BRANKO ZAKOTNIK, BARBARA ŽUMER, KATARINA KARNER, MARTA DREMELJ, BORIS JANČAR, SIMONA JEREB and CVETKA GRAŠIČ-KUHAR
Anticancer Research July 2018, 38 (7) 4213-4220; DOI: https://doi.org/10.21873/anticanres.12717
PRIMOŽ STROJAN
1Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
2Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
BRANKO ZAKOTNIK
3Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia
BARBARA ŽUMER
1Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
KATARINA KARNER
1Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
MARTA DREMELJ
1Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
BORIS JANČAR
1Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
SIMONA JEREB
4Department of Radiology, Institute of Oncology, Ljubljana, Slovenia
CVETKA GRAŠIČ-KUHAR
3Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia
In this issue
Skin Reaction to Cetuximab as a Criterion for Treatment Selection in Head and Neck Cancer
PRIMOŽ STROJAN, BRANKO ZAKOTNIK, BARBARA ŽUMER, KATARINA KARNER, MARTA DREMELJ, BORIS JANČAR, SIMONA JEREB, CVETKA GRAŠIČ-KUHAR
Anticancer Research Jul 2018, 38 (7) 4213-4220; DOI: 10.21873/anticanres.12717
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.